Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer

International Journal of Medical Sciences

Volumn 5, Issue 3, 2008, Pages 133-142

  Li, Jianduan ^a   Olson, Lisa M ^a,b   Zhang, Zhengyan ^a   Li, Lina ^a,c   Bidder, Miri ^a   Nguyen, Loan ^a   Pfeifer, John ^a   Rader, Janet S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biological markers; Deubiquitinating enzyme; Ovarian cancer; Ubiquitin specific peptidase 36 (USP36)

Indexed keywords

PEPTIDASE; UBIQUITIN SPECIFIC PEPTIDASE 36;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARY CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 45849134528     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.5.133     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106-130.
2. Menon U and Jacobs IJ. Recent developments in ovarian cancer screening. Curr Opin Obstet Gynecol. 2000; 12: 39-42.
3. Tsao SW, Mok CH, Knapp RC, et al. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol. 1993; 48: 5-10.
4. Liang P and Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992; 257: 967-971.
5. Scully RE. Ovarian tumors. A review. Am J Pathol. 1977; 87: 686-720.
6. Daviet L and Colland F. Targeting ubiquitin specific proteases for drug discovery. Biochimie. 2008; 90: 270-283.
7. Kim MS, Kim YK, Kim YS, et al. Deubiquitinating enzyme USP36 contains the PEST motif and is polyubiquitinated. Biochem Biophys Res Commun. 2005; 330: 797-804.
8. Quesada V, Diaz-Perales A, Gutierrez-Fernandez A, et al. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun. 2004; 314: 54-62.
9. Kruk PA, Maines-Bandiera SL, and Auersperg N. A simplified method to culture human ovarian surface epithelium. Lab Invest. 1990; 63: 132-136.
10. Chirgwin JM, Przybyla AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18: 5294-5299.
11. Nicoletti A and Sassy-Prigent C. An alternative quantitative polymerase chain reaction method. Anal Biochem. 1996; 236: 229-241.
12. Feng G, Li G, Gentil-Perret A, et al. Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res. 2008; 28: 321-326.
13. Kobayashi N, Yang J, Ueda A, et al. RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene. 2007; 396: 236-247.
14. Ciechanover A. The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting. Biochem Soc Trans. 2003; 31: 474-481.
15. Wing SS. Deubiquitinating enzymes--the importance of driving in reverse along the ubiquitin-proteasome pathway. Int J Biochem Cell Biol. 2003; 35: 590-605.
16. Ovaa H, Kessler BM, Rolen U, et al. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc Natl Acad Sci U S A. 2004; 101: 2253-2258.
17. Hibi K, Liu Q, Beaudry GA, et al. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res. 1998; 58: 5690-5694.
18. Hibi K, Westra WH, Borges M, et al. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol. 1999; 155: 711-715.
19. Caballero OL, Resto V, Patturajan M, et al. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene. 2002; 21: 3003-3010.
20. Gilchrist CA and Baker RT. Characterization of the ubiquitin-specific protease activity of the mouse/human Unp/Unph oncoprotein. Biochim Biophys Acta. 2000; 1481: 297-309.
21. Kim MS, Yoo KJ, Kang I, et al. A novel cysteine protease HeLa DUB-1 responsible for cleaving the ubiquitin in human ovarian cancer cells. Int J Oncol. 2004; 25: 373-379.
22. Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002; 2: 315-319.
23. Swarup V and Rajeswari MR. Circulating (cell-free) nucleic acids - a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007; 581: 795-799.
24. Li Y, Elashoff D, Oh M, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol. 2006; 24: 1754-1760.